Cystic Fibrosis-Related Pancreatic Cysts Decrease in Size and Number Upon Treatment With Cystic Fibrosis Transmembrane Conductance Regulator Modulators

被引：1
|
作者：
de Vries, Jonathan M. [1 ]
Green, Deanna [2 ]
Kucera, Jennifer N. [3 ]
Fabbrini, Abigail L. [1 ]
Kidder, Molly [4 ]
Brown, Jerry [1 ]
Wilsey, Michael [1 ]
机构：
[1] Johns Hopkins All Childrens Hosp, Dept Pediat Gastroenterol & Nutr, St Petersburg, FL 33701 USA
[2] Johns Hopkins All Childrens Hosp, Dept Pediat Pulmonol, St Petersburg, FL USA
[3] Johns Hopkins All Childrens Hosp, Dept Radiol, St Petersburg, FL USA
[4] Johns Hopkins All Childrens Hosp, Dept Pediat & Adolescent Med, St Petersburg, FL USA
来源：
PANCREAS | 2020年 / 49卷 / 06期
关键词：
D O I：
10.1097/MPA.0000000000001567
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E50 / E51
页数：2
相关论文
共 50 条
  • [31] Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis
    Giuseppe Fabio Parisi
    Federico Mòllica
    Alessandro Giallongo
    Maria Papale
    Sara Manti
    Salvatore Leonardi
    Egyptian Journal of Medical Human Genetics, 23
  • [32] A current review of the safety of cystic fibrosis transmembrane conductance regulator modulators
    Gavioli, Elizabeth Marie
    Guardado, Nerli
    Haniff, Farah
    Deiab, Nouran
    Vider, Etty
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (02) : 286 - 294
  • [33] Therapeutic pipeline for individuals with cystic fibrosis with mutations nonresponsive to current cystic fibrosis transmembrane conductance regulator modulators
    Fajac, Isabelle
    Sermet-Gaudelus, Isabelle
    CURRENT OPINION IN PULMONARY MEDICINE, 2021, 27 (06) : 567 - 574
  • [34] Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function
    Shuzhong Zhang
    Chandra L. Shrestha
    Benjamin T. Kopp
    Scientific Reports, 8
  • [35] Effectiveness and Safety of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Children With Cystic Fibrosis: A Meta-Analysis
    Li, Qiyu
    Liu, Siyuan
    Ma, Xuemei
    Yu, Jiaping
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [36] The Impact of Highly Effective Cystic Fibrosis Transmembrane Conductance Regulator Modulators on the Health of Female Subjects With Cystic Fibrosis
    Taylor-Cousar, Jennifer L.
    Shteinberg, Michal
    Cohen-Cymberknoh, Malena
    Jain, Raksha
    CLINICAL THERAPEUTICS, 2023, 45 (03) : 278 - 289
  • [37] Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators
    Burke, Andrew
    Thomson, Rachel M. M.
    Wainwright, Claire E. E.
    Bell, Scott C. C.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 44 (02) : 287 - 296
  • [38] Advanced Cystic Fibrosis Lung Disease and Lung Transplantation in the Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulators
    O'Carroll, Mark
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 44 (02) : 260 - 268
  • [39] Cystic Fibrosis Transmembrane Conductance Regulator-Modifying Medications: The Future of Cystic Fibrosis Treatment
    Pettit, Rebecca S.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (7-8) : 1065 - 1075
  • [40] Optimising the care and quality of life of people with cystic fibrosis: the influence of cystic fibrosis transmembrane conductance regulator modulators
    Shaw, Nicola
    Collins, Sarah
    Smith, Thomas
    McCulloch, Anna
    Ketchell, Ian
    Edwards, Viv
    Blaikie, Lesley
    Daniels, Tracey
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2021, 82 (11)
12345